Literature DB >> 2563607

Scoring atopic dermatitis: the simpler the better?

C Costa1, A Rilliet, M Nicolet, J H Saurat.   

Abstract

Two scoring methods evaluating the severity of atopic dermatitis have been compared. One was simple, quick and compatible with a busy outpatients clinic. The other was more complicated and time consuming; it took into account most of the evaluable clinical signs of disease activity in each involved site. There was a highly significant correlation between the two methods of scoring, thus validating the simplest one; furthermore, the more complicated method was less reproducible than the simplest when used by two physicians on the same patient. This suggests that a simple and feasible scoring method is meaningful in keeping records at each visit in any patient with atopic dermatitis. Such records may then be used in retrospect for the evaluation of any new therapy.

Entities:  

Mesh:

Year:  1989        PMID: 2563607

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  13 in total

1.  Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26.

Authors:  N Katoh; S Hirano; M Suehiro; K Ikenaga; T Yamashita; N Sugawara; H Yasuno
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  [Measurement of disease severity in dermatology].

Authors:  S Deckert; C Apfelbacher; J Schmitt
Journal:  Hautarzt       Date:  2015-09       Impact factor: 0.751

3.  In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitis.

Authors:  M Rupprecht; R Rupprecht; N Wodarz; H U Braner; J Kornhuber; H U Koch; P Riederer; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Recombinant human interferon gamma (Gamma Immunex) in treatment of atopic dermatitis.

Authors:  Yunes Panahi; Seyyed Masoud Davoudi; Nima Madanchi; Ehsan Abolhasani
Journal:  Clin Exp Med       Date:  2011-11-19       Impact factor: 3.984

5.  Interventions to reduce Staphylococcus aureus in the management of eczema.

Authors:  Susannah Mc George; Sanja Karanovic; David A Harrison; Anjna Rani; Andrew J Birnie; Fiona J Bath-Hextall; Jane C Ravenscroft; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-10-29

Review 6.  Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids.

Authors:  Roman Schiffner; Julia Schiffner-Rohe; Michael Landthaler; Wilhelm Stolz
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  High affinity IgE receptor (Fc epsilon RI) expression on eosinophils infiltrating the lesions and mite patch tested sites in atopic dermatitis.

Authors:  Y Tanaka; M Takenaka; Y Matsunaga; S Okada; S Anan; H Yoshida; C Ra
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 8.  Emollients and moisturisers for eczema.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Robin Christensen; Adriana Lavrijsen; Bernd WM Arents
Journal:  Cochrane Database Syst Rev       Date:  2017-02-06

Review 9.  Oral evening primrose oil and borage oil for eczema.

Authors:  Joel T M Bamford; Sujoy Ray; Alfred Musekiwa; Christel van Gool; Rosemary Humphreys; Edzard Ernst
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

10.  Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Authors:  Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2021-08-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.